Boji Medical Technology Co.,Ltd. (SHE:300404)

Market Cap	4.05B +28.8%
Revenue (ttm)	770.19M +2.3%
Net Income	7.41M -83.4%
EPS	0.02 -83.5%
Shares Out	383.07M
PE Ratio	545.69
Forward PE	40.62
Dividend	0.01 (0.11%)
Ex-Dividend Date	Jul 15, 2025

Volume	9,573,853
Average Volume	14,254,721
Open	10.62
Previous Close	10.62
Day's Range	10.54 - 10.82
52-Week Range	7.77 - 13.15
Beta	0.26
RSI	52.87
Earnings Date	Apr 25, 2026

About Boji Medical Technology

Boji Medical Technology Co.,Ltd. provides professional contract research services for research and development, and production of drugs and medical devices to pharmaceutical enterprises in China and internationally. It offers pre-clinical research, clinical research, and other consulting services. The company also provides clinical drug production, pilot test scale-up, process verification batch production, and drug registration and approval services. In addition, it engages in the screening, evaluation, verification, and trading of technologic...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1998
• Employees: 1,205
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300404

Financial Performance

In 2024, Boji Medical Technology's revenue was 742.02 million, an increase of 33.50% compared to the previous year's 555.83 million. Earnings were 28.78 million, an increase of 18.23%.